Peter B Heifetz
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$2.5MFederal grants as PI4 awards
2Patents grantedLatest Aug 19, 2025
18Papers1,809 citations
Federal awards and patents by year
AwardsPatents
4 awards · $2.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 24, 2025 | NIH | STTR Phase I Engineered Monothiol Thioredoxin for Treatment of Radiation Induced Lung Injury | $509K | ORPRO THERAPEUTICS INC |
| Aug 6, 2018 | NIH | SBIR Phase II Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis | $1.5M | ORPRO THERAPEUTICS INC |
| Mar 15, 2018 | NIH | SBIR Phase I Mucoadhesive drug conjugates for controlled-release inhalation delivery | $228K | ORPRO THERAPEUTICS INC |
| Jan 18, 2018 | NIH | SBIR Phase II Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis | $224K | ORPRO THERAPEUTICS INC |
3 patents as inventor
- US 12390511ORPRO THERAPEUTICS INCAug 19, 2025
- US 9168290ORPRO THERAPEUTICS INCOct 27, 2015
- US ORPRO THERAPEUTICS INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#793
Awards as PI#566
Patents#102
Companies
- ORPRO THERAPEUTICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.